Pancreatic Cancer Second Opinion from MD Anderson Specialists

Pancreatic cancer is among the most complex malignancies to diagnose and treat, making a second opinion from a world-leading center essential. MD Anderson Cancer Center consistently ranks as one of the top institutions globally for pancreatic cancer care, and through Medebound Health, patients worldwide can access pancreatic cancer second opinion review from MD Anderson-affiliated specialists without traveling to Houston.

Our secure platform lets you upload CT scans, MRI images, endoscopic ultrasound results, CA 19-9 lab values, pathology reports, and treatment records. An expert oncologist then performs a thorough review, assessing resectability, staging accuracy, gemcitabine-based versus FOLFIRINOX regimen suitability, and eligibility for clinical trials at top US centers including MD Anderson, MSKCC, and Mayo Clinic.

The pancreatic cancer second opinion report is delivered within 5–7 business days and includes a detailed written analysis plus a one-on-one video consultation with the reviewing oncologist. Medebound Health's care coordinators are available throughout the process to answer logistical questions and ensure no document is missing.

More than 3,000 patients have relied on Medebound Health since 2016 for expert oncology second opinions. For patients in India, the Middle East, Southeast Asia, and Europe, this service brings MD Anderson-level expertise directly to their current care team.

Do not navigate a pancreatic cancer diagnosis alone. A pancreatic cancer second opinion from an MD Anderson-affiliated specialist through Medebound Health may identify new surgical options, different chemotherapy regimens, or clinical trial eligibility that changes your prognosis. Start your case submission today.

Frequently Asked Questions

Why is a second opinion especially important for pancreatic cancer?
Pancreatic cancer staging, resectability assessment, and chemotherapy selection are highly nuanced. A second opinion from an MD Anderson-affiliated specialist may reveal surgical options or clinical trials not identified locally.

Can MD Anderson specialists review borderline resectable pancreatic cancer cases?
Yes. Medebound Health facilitates review of all pancreatic cancer stages including borderline resectable cases, where the distinction between surgery and neoadjuvant chemotherapy is critical.

How do I send my CT scans and pathology slides for a pancreatic cancer second opinion?
Medebound Health provides a secure digital upload portal. Imaging files can be shared via DICOM-compatible transfer, and pathology slides can be sent as digital scans or physical slides when needed.